Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma: a large randomized clinical trial

B Fallahi, D Beiki, A Takavar… - Nuclear medicine …, 2012 - journals.lww.com
Objectives Radioiodine ablation of thyroid tissue remains the cornerstone of treatment for
patients with differentiated thyroid carcinoma after thyroidectomy. Selecting an optimal dose …

Diagnostic 131I whole-body scintigraphy 1 year after thyroablative therapy in patients with differentiated thyroid cancer: correlation of results to the individual risk …

F Berger, U Friedrich, P Knesewitsch… - European journal of …, 2011 - Springer
Purpose 131 I whole-body scan (WBS) and serum thyroglobulin (TG) are important in
detecting thyroid remnants or recurrent disease in patients with differentiated thyroid cancer …

Timing of post 131I ablation diagnostic whole body scan in differentiated thyroid cancer patients

M Winter, J Winter, A Heinzel… - Nuklearmedizin …, 2015 - thieme-connect.com
Aim: to determine whether the first three months after 131I ablation is too early to perform
radioiodine diagnostic whole body scintigraphy (dxWBS) in differentiated thyroid carcinoma …

Thyroid stunning

LF Morris, AD Waxman, GD Braunstein - Thyroid, 2003 - liebertpub.com
Debates regarding thyroid stunning—a phenomenon whereby a diagnostic dose of
radioiodine decreases uptake of a subsequent therapeutic dose by remnant thyroid tissue or …

[PDF][PDF] Prospective randomized trial for evaluation of efficacy of low versus high dose I-131 for post operative remnant ablation in differentiated thyroid cancer

S Sirisalipoch, V Buachum, P Pasawang… - 2006 - cuir.chula.ac.th
นิพนธ์ต้นฉบับศศิธร เล่ม 10 Volume 50 หน้า 695 - 706.pmd Page 1 Chula Med J Vol. 50 No. 10
October 2006 Sirisalipoch S, Buachum V, Pasawang P, Tepmongkol S, Boonvisut S …

Diagnostic 131I whole body scanning after thyroidectomy and ablation for differentiated thyroid cancer

H Taylor, S Hyer, L Vini, B Pratt, G Cook… - European journal of …, 2004 - academic.oup.com
Objective To assess the value of the diagnostic whole body (131) I scan after thyroidectomy
and (131) I ablation. Design Retrospective analysis of all patients with differentiated thyroid …

[PDF][PDF] Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer

K Johansen, NJY Woodhouse… - Journal of Nuclear …, 1991 - Soc Nuclear Med
RESULTS Table 1reveals that the clinical characteristics of the patients in the group
receiving a low (1073 MBq) and a high (3700 MBq) â€@ †I dose were very similar. In this …

Thyroid lobe ablation with iodine-131 in patients with differentiated thyroid carcinoma: a randomized comparison between 1.1 and 3.7 GBq activities

L Giovanella, A Piccardo, G Paone… - Nuclear medicine …, 2013 - journals.lww.com
Purpose The present study was undertaken to evaluate the ablation rate after administration
of 1.1 or 3.7 GBq of iodine-131 (131 I) to patients with low-risk differentiated thyroid …

Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?

AF Cailleux, E Baudin, JP Travagli… - The Journal of …, 2000 - academic.oup.com
A diagnostic iodine-131 (131I) total body scan (TBS) is usually recommended 6 to 12
months after thyroid ablation for differentiated thyroid carcinoma. Its usefulness was …

Ablative treatment of thyroid cancer with high doses of 131I without pre-therapy scanning

PWS Rosário, ÁL Barroso, LL Rezende… - Nuclear medicine …, 2005 - journals.lww.com
Objective To determine the success of ablative treatment using fixed high doses of 131 I in
patients with thyroid cancer. Methods A retrospective study was conducted on 274 patients …